Guizhou Ruihe's future drug research and development strategy: Chinese medicine-based, chemical medicine collaboration, innovation-led, Chinese medicine and chemical medicine equal development, complementary advantages

Drug research and development strategy (R-D strategy): Chinese medicine-based, chemical drug collaboration, innovation-led, Chinese medicine and chemical drug development, complementary advantages of the company's research and development to "clinical unmet needs" as the guide, adhere to the "differentiated" research and development strategy, strengthen the construction of research and development platform, multi-level, wide-area project research and development.

Short-term focus on liver disease digestion and drug use, cardiovascular and cerebrovascular drugs, transdermal absorption of external drugs, mental nerve drugs and other major diseases, long-term to anti-tumor, immune targeting and other therapeutic areas to expand. Through the rational layout of "research and development generation, planning generation, transformation generation", to create Ruihe characteristic research and development pipeline product group.

The company's research and development work to industrialization as the focus of research and development, research and development work under the leadership of the general manager, the technical committee of the project, drug screening and other process matters of collective decision-making. The company will be based on the actual situation, take the combination of self-research and outsourcing research and development of new products, focus on accelerating the research and development of core varieties, improve research and development efficiency. Carry out in-depth industry-university-research cooperation in personnel training, transformation of scientific research achievements, and technical support.